Postprandial hyperglycaemia;Postprandial hyperglykæmi

Ugeskrift for Laeger

Volumn 165, Issue 33, 2003, Pages 3149-3153

  Madsbad, Sten ^a   Brock, Birgitte ^a   Schmitz, Ole ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIAGNOSTIC VALUE; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MICROANGIOPATHY; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; REVIEW; RISK FACTOR; ARTERIOSCLEROSIS; BLOOD; DIABETES MELLITUS; DIABETIC ANGIOPATHY; METABOLISM;

ARTERIOSCLEROSIS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; HUMANS; HYPERGLYCEMIA; POSTPRANDIAL PERIOD; RISK FACTORS;

EID: 0347135670     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Bruce DG, Chisholm DJ, Storlien LH et al. Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes 1988;37:736-44 (1b).
2. Postprandial blood glucose. American Diabetes Association. Diabetes Care 2001;24:775-8 (1a).
3. Hanefeld M, Fischer S, Julius U et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996;39:1577-83 (2b).
4. Kuusisto J, Mykkanen L, Pyorala K et al. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994;43:960-7 (2b).
5. Uusitupa MI, Niskanen LK, Siitonen O et al. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993;36:1175-84 (2b).
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53 (1b).
7. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 1999;354:617-21 (2b).
8. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161:397-405 (2b).
9. De Vegt F. Dekker JM. Ruhe HG et al. Hyperglycaemia is associated with allcause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 1999;42:926-31 (2b).
10. Balkau B, Shipley M, Jarrett RJ et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men, 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998;21:360-7 (2b).
11. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study. Diabetes Care 1998;21:1236-9 (2b).
12. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979;2:131-41 (2b).
13. Donahue RP, Abbott RD, Reed DM et al. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry, Honolulu Heart Program. Diabetes 1987;36:689-92 (2b).
14. Shaw JE, Hodge AM, de Courten M et al. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetclogia 1999;42:1050-4 (2b).
15. Tominaga M, Eguchi H, Manaka H et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999;22:920-4 (2b).
16. Coutinho M, Gerstein HC, Wang Y et al. The relationship between glucose and incident cardiovascular events. Diabetes Care 1999;22:233-40 (2a).
17. Temelkova-Kurktschiev TS, Koehler C, Henkel E et al. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbAlc level. Diabetes Care 2000;23:1830-4 (2b).
18. Saydah SH, Miret M, Sung J et al. Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 2001;24:1397-402 (2b).
19. Stern MP, Fatehi P, Williams K et al. Predicting future cardiovascular disease: do we need the oral glucose tolerance test? Diabetes Care 2002;25:1851-6 (2b).
20. Meigs JB, Nathan DM, D'Agostino RB et al. Fasting and postchallenge glycemia and cardiovascular disease risk: the framingham offspring study. Diabetes Care 2002;25:1845-50 (2b).
21. Ceriello A. The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Res Rev 2000;16:125-32 (2a).
22. Ceriello A. The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med 1998;15:188-93 (2b).
23. Lefebvre PJ, Scheen AJ. The postprandial state and risk of cardiovascular disease. Diabet Med 1998;15 (suppl 4):S63-S68 (2a).
24. Bierman EL, George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterioscler Thromb 1992;12:647-56 (1b).
25. Makita Z, Radoff S, Rayfield EJ et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991;325:836-42 (3b).
26. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50 (2a).
27. Badimon JJ, Fuster V, Chesebro JH et al. Coronary atherosclerosis. Circulation 1993;87(supp13):113-16 (2a).
28. Haffner S. The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point. Int. J Clin Pract Suppl 2001:24-6 (2a).
29. Wiseman MJ, Saunders AJ, Keen H et al. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 1985;312:617-21 (4).
30. Takeuchi A, Throckmorton DC, Brogden AP et al. Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells. Am J Physiol 1995;268(1 Pt 2): F13-F19 (4).
31. Perrott RL, North RV, Drasdo N et al. The influence of plasma glucose upon pulsatile ocular blood flow in subjects with type II diabetes mellitus. Diabetologia 2001;44:700-5 (3b).
32. Patel V, Rassam SM, Chen HC et al. Oxygen reactivity in diabetes mellitus: effect of hypertension and hyperglycaemia. Clin Sci (Coich) 1994;86:689-95 (3b).
33. Gregersen G. Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients. Diabetologia 1968;4:273-7 (4).
34. Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 1988;94:739-44 (4).
35. Marfella R, Nappo F, De Angelis L et al. The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 2000;43:571-5 (3b).
36. De Veciana M, Major CA, Morgan MA et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333:1237-41 (1b).